(NASDAQ: SGHT) Sight Sciences's forecast annual revenue growth rate of 10.8% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.31%.
Sight Sciences's revenue in 2026 is $83,377,000.On average, 10 Wall Street analysts forecast SGHT's revenue for 2026 to be $5,076,909,158, with the lowest SGHT revenue forecast at $4,858,760,718, and the highest SGHT revenue forecast at $5,252,088,967. On average, 10 Wall Street analysts forecast SGHT's revenue for 2027 to be $5,679,020,889, with the lowest SGHT revenue forecast at $5,344,636,790, and the highest SGHT revenue forecast at $5,978,148,675.
In 2028, SGHT is forecast to generate $6,151,124,963 in revenue, with the lowest revenue forecast at $5,728,049,200 and the highest revenue forecast at $6,444,193,070.